Resiliency Training in Adolescents With NF1 and NF2 (NCT03873610) | Clinical Trial Compass
Active ā Not RecruitingNot Applicable
Resiliency Training in Adolescents With NF1 and NF2
United States200 participantsStarted 2019-12-15
Plain-language summary
This randomized controlled trial for resiliency training in adolescents with Neurofibromatosis 1 and Neurofibromatosis 2 via secure live video to determine the efficacy two stress and symptom management programs. Both programs are 8 week group programs.
Who can participate
Age range12 Years ā 17 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Has a diagnosis of NF1 or NF2 and is between the ages of 12-17
* Is capable of completing and fully understanding the informed consent process/assent and the study procedures and assessments in English; has parental approval for participation
* English speaking and at least a 3rd grade self-reported and parent reported reading level
* Self reported/parent reported difficulties coping with stress and NF symptoms
Exclusion Criteria:
* Has major medical co-morbidity not NF related expected to worsen in the next 12 months
* Recent (within past 3 months) change in antidepressant medication
* Recent participation in cognitive behavioral therapy or relaxation therapy (within past 3 months)
* Has significant mental health diagnosis requiring immediate treatment (e.g., untreated bipolar disorder, psychotic disorder, active substance dependence)
* Unable or unwilling to complete assessments electronically via REDCap
* Unable or unwilling to participate in group videoconferencing sessions
* Unable or unwilling to participate along with at least 1 parent in a video screening session